rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2001-12-14
|
pubmed:abstractText |
The Diabetes Control and Complications Trial (DCCT) demonstrated that intensive therapy of type 1 diabetes mellitus reduces the risk of development and progression of microvascular complications. The Epidemiology of Diabetes Interventions and Complications (EDIC) study assessed whether these benefits persisted after the end of DCCT. Results for the adolescent DCCT cohort are reported here.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-3476
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
804-12
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11743505-Adolescent,
pubmed-meshheading:11743505-Adult,
pubmed-meshheading:11743505-Albuminuria,
pubmed-meshheading:11743505-Cohort Studies,
pubmed-meshheading:11743505-Diabetes Mellitus, Type 1,
pubmed-meshheading:11743505-Diabetic Nephropathies,
pubmed-meshheading:11743505-Diabetic Retinopathy,
pubmed-meshheading:11743505-Female,
pubmed-meshheading:11743505-Fluorescein Angiography,
pubmed-meshheading:11743505-Hemoglobin A, Glycosylated,
pubmed-meshheading:11743505-Humans,
pubmed-meshheading:11743505-Hypoglycemic Agents,
pubmed-meshheading:11743505-Insulin,
pubmed-meshheading:11743505-Male,
pubmed-meshheading:11743505-Odds Ratio,
pubmed-meshheading:11743505-Regression Analysis,
pubmed-meshheading:11743505-Time Factors,
pubmed-meshheading:11743505-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
|
pubmed:affiliation |
Yale University School of Medicine, New Haven, CT, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|